EN
HI
Genpharmasec Chart
Genpharmasec Share Key Metrics
Volume
10.73 L
Market Cap
69.21 CR
LTQ@LTP
8@1.19
ATP
1.21
Var Margin
26.81 %
Circuit Range
1.19-1.31
Delivery %
96.44 %
Value
12.99 L
ASM/GSM
No
Market Lot
1
Summary
Genpharmasec share price is ₹1.19 as of 29 May, 2026. The stock Genpharmasec intraday movement has stayed between ₹1.19 and ₹1.29, while on a 52-week basis,Genpharmasec price 52 week high is ₹2.33 & its 52 week low is ₹0.75.
In terms of trading activity, Genpharmasec has recorded a volume of 1073256 shares, The Genpharmasec has a market cap of ₹553719700 CR. The stock’s Average Traded Price (ATP) stands at ₹1.21, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 8 @ ₹1.19.
Genpharmasec operates within a circuit range of ₹1.19 – ₹1.31, with a Value of ₹12.99 L. The Delivery Percentage for the day is 96.44%. Additionally, Genpharmasec currently falls under the No framework, and trades with a market lot size of 1.
Genpharmasec Fundamentals
View MoreP/E Ratio
43.18
P/B Ratio
1.04
Div. Yield
0
Sector P/E
145.45
Sector P/B
1.96
Sec. Div. Yield
79.26
Genpharmasec Resistance and Support
Pivot 1.28
Resistance
First Resistance
1.31
Second Resistance
1.36
Third Resistance
1.39
Support
First Support
1.23
Second Support
1.2
Third Support
1.15
Genpharmasec Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-21 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-09-02 | Others |
| 2025-08-07 | Quarterly Results |
| 2025-05-21 | Audited Results |
| 2025-03-24 | Independent Director Meeting |
| 2025-02-10 | Quarterly Results |
Genpharmasec News
Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March, 2026.
Genpharmasec confirmed no deviation in the utilization of Rs. 48.45 crore proceeds from its Rights Issue for the quarter ended March 31, 2026. This compliance report assures investors that the raised capital was deployed as per stated objectives.
May 21 2026 17:40:59
Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday, May 21, 2026.
Genpharmasec board approved audited financial results for FY26. Consolidated revenue reached ₹139.94 cr (up 315% YoY) and net profit was ₹0.56 cr (down 65% YoY). Two subsidiaries are loss-making with eroded net worth, raising going concern issues despite management's financial support assurance.
May 21 2026 17:26:37
Genpharmasec Management
| Name | Position |
|---|---|
| Sohan Chaturvedi | Whole Time Director & Chief Financial Officer |
| Rajesh Sadhwani | Non Independent & Non Executive Director |
Genpharmasec Similar Stocks
SGL Resources Ltd.
2.91
0.04 (1.39%)
Kabsons Industries Ltd.
19.30
-0.99 (4.88%)
Ironwood Education Ltd.
42.84
0.24 (0.56%)
Royal Sense Ltd.
127.05
-5.95 (4.47%)
Shine Fashion (India) Ltd.
27.40
0.00 (0.00%)
Future Consumer Ltd.
0.34
0.00 (0.00%)
Mysore Petro Chemicals Ltd.
97.92
-4.08 (4.00%)
Future Market Networks Ltd.
10.40
-0.09 (0.86%)
Genpharmasec FAQs
The Buying Price of Genpharmasec share is 1.19 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Genpharmasec stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Genpharmasec, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Genpharmasec shares is 43.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Genpharmasec shares is 1.04. Useful to assess the stock's value relative to its book value.
To assess Genpharmasec’s valuation compare Sector P/E, P/B which are 145.45 & 1.96 with sector averages, along with growth rates and financial metrics.
The Market Cap of Genpharmasec is 69.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Genpharmasec share price is 2.33 & 0.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Genpharmasec belongs to the Miscellaneous sector.
